SCIENTIFIC HUB

Follow the evidence.

1.257 articles found

“Parkinson LRRK2” Clear search

Open access

Long-term inhibition of mutant LRRK2 hyper-kinase activity reduced mouse brain α-synuclein oligomers without adverse effects.

Ho PW, Chang EE, Leung CT, Liu H, Malki Y, Pang SY, Choi ZY, Liang Y, Lai WS, Ruan Y, Leung KM, Yung S, Mak JC, Kung MH, Ramsden DB, Ho SL.

NPJ Parkinsons Dis · 2022-09-10

DOI: 10.1038/s41531-022-00386-9PMID: 36088364

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.
Source record

The APP intracellular domain promotes <i>LRRK2</i> expression to enable feed-forward neurodegenerative mechanisms in Parkinson's disease.

Zhang ZW, Tu H, Jiang M, Vanan S, Chia SY, Jang SE, Saw WT, Ong ZW, Ma DR, Zhou ZD, Xu J, Guo KH, Yu WP, Ling SC, Margolin RA, Chain DG, Zeng L, Tan EK.

Sci Signal · 2022-08-23

DOI: 10.1126/scisignal.abk3411PMID: 35998231

A bibliographic record traceable to Europe PMC. Türkçe başlık: makine çevirisi, editoryal kontrol bekliyor.

Records come from scientific sources. Bibliographic counts do not represent completed translations or editorial approvals.

Filters

Filters

Clear
Publication year
Research area
Author
Journal
Publication type
Source & language
Open accessAccess does not establish reuse rights.